Correlation Between Rbc Emerging and Pharmaceuticals Ultrasector

Can any of the company-specific risk be diversified away by investing in both Rbc Emerging and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rbc Emerging and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rbc Emerging Markets and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Rbc Emerging and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rbc Emerging with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rbc Emerging and Pharmaceuticals Ultrasector.

Diversification Opportunities for Rbc Emerging and Pharmaceuticals Ultrasector

0.0

Correlation Coefficient

Rbc Emerging  Pharmaceuticals Ultrasector

Pay attention - limited upside

The 3 months correlation between Rbc and PHARMACEUTICALS is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Rbc Emerging Markets and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Rbc Emerging is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rbc Emerging Markets are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Rbc Emerging i.e., Rbc Emerging and Pharmaceuticals Ultrasector go up and down completely randomly.

Pair Corralation between Rbc Emerging and Pharmaceuticals Ultrasector

If you would invest  980.00  in Rbc Emerging Markets on July 25, 2025 and sell it today you would earn a total of  116.00  from holding Rbc Emerging Markets or generate 11.84% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Rbc Emerging Markets  vs.  Pharmaceuticals Ultrasector Pr

Rbc Emerging Markets

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Rbc Emerging Markets are ranked lower than 16 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak basic indicators, Rbc Emerging may actually be approaching a critical reversion point that can send shares even higher in November 2025.

Pharmaceuticals Ultrasector

Risk-Adjusted Performance

Good

Over the last 90 days Pharmaceuticals Ultrasector Profund has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong forward indicators, Pharmaceuticals Ultrasector is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Rbc Emerging and Pharmaceuticals Ultrasector

The main advantage of trading using opposite Rbc Emerging and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rbc Emerging position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.

The idea behind Rbc Emerging Markets and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.